These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1033 related articles for article (PubMed ID: 28710827)

  • 121. Effects of hawthorn ( Crataegus pentagyna) leaf extract on electrophysiologic properties of cardiomyocytes derived from human cardiac arrhythmia-specific induced pluripotent stem cells.
    Pahlavan S; Tousi MS; Ayyari M; Alirezalu A; Ansari H; Saric T; Baharvand H
    FASEB J; 2018 Mar; 32(3):1440-1451. PubMed ID: 29133340
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Steps toward Maturation of Embryonic Stem Cell-Derived Cardiomyocytes by Defined Physical Signals.
    Shen N; Knopf A; Westendorf C; Kraushaar U; Riedl J; Bauer H; Pöschel S; Layland SL; Holeiter M; Knolle S; Brauchle E; Nsair A; Hinderer S; Schenke-Layland K
    Stem Cell Reports; 2017 Jul; 9(1):122-135. PubMed ID: 28528699
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Epigenetic Priming of Human Pluripotent Stem Cell-Derived Cardiac Progenitor Cells Accelerates Cardiomyocyte Maturation.
    Biermann M; Cai W; Lang D; Hermsen J; Profio L; Zhou Y; Czirok A; Isai DG; Napiwocki BN; Rodriguez AM; Brown ME; Woon MT; Shao A; Han T; Park D; Hacker TA; Crone WC; Burlingham WJ; Glukhov AV; Ge Y; Kamp TJ
    Stem Cells; 2019 Jul; 37(7):910-923. PubMed ID: 31087611
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Cardiac muscle patches containing four types of cardiac cells derived from human pluripotent stem cells improve recovery from cardiac injury in mice.
    Lou X; Tang Y; Ye L; Pretorius D; Fast VG; Kahn-Krell AM; Zhang J; Zhang J; Qiao A; Qin G; Kamp T; Thomson JA; Zhang J
    Cardiovasc Res; 2023 May; 119(4):1062-1076. PubMed ID: 36647784
    [TBL] [Abstract][Full Text] [Related]  

  • 125. A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes.
    Hemmi N; Tohyama S; Nakajima K; Kanazawa H; Suzuki T; Hattori F; Seki T; Kishino Y; Hirano A; Okada M; Tabei R; Ohno R; Fujita C; Haruna T; Yuasa S; Sano M; Fujita J; Fukuda K
    Stem Cells Transl Med; 2014 Dec; 3(12):1473-83. PubMed ID: 25355733
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Human embryonic and induced pluripotent stem cell-derived cardiomyocytes exhibit beat rate variability and power-law behavior.
    Mandel Y; Weissman A; Schick R; Barad L; Novak A; Meiry G; Goldberg S; Lorber A; Rosen MR; Itskovitz-Eldor J; Binah O
    Circulation; 2012 Feb; 125(7):883-93. PubMed ID: 22261196
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Inhibition of mTOR Signaling Enhances Maturation of Cardiomyocytes Derived From Human-Induced Pluripotent Stem Cells via p53-Induced Quiescence.
    Garbern JC; Helman A; Sereda R; Sarikhani M; Ahmed A; Escalante GO; Ogurlu R; Kim SL; Zimmerman JF; Cho A; MacQueen L; Bezzerides VJ; Parker KK; Melton DA; Lee RT
    Circulation; 2020 Jan; 141(4):285-300. PubMed ID: 31707831
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Differential Sarcomere and Electrophysiological Maturation of Human iPSC-Derived Cardiac Myocytes in Monolayer vs. Aggregation-Based Differentiation Protocols.
    Jeziorowska D; Fontaine V; Jouve C; Villard E; Dussaud S; Akbar D; Letang V; Cervello P; Itier JM; Pruniaux MP; Hulot JS
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587156
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Ultrastructural comparison of developing mouse embryonic stem cell- and in vivo-derived cardiomyocytes.
    Baharvand H; Piryaei A; Rohani R; Taei A; Heidari MH; Hosseini A
    Cell Biol Int; 2006 Oct; 30(10):800-7. PubMed ID: 16877013
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Generation of electrophysiologically functional cardiomyocytes from mouse induced pluripotent stem cells.
    Wang H; Xi Y; Zheng Y; Wang X; Cooney AJ
    Stem Cell Res; 2016 Mar; 16(2):522-30. PubMed ID: 26972055
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Exosomes From Induced Pluripotent Stem Cell-Derived Cardiomyocytes Promote Autophagy for Myocardial Repair.
    Santoso MR; Ikeda G; Tada Y; Jung JH; Vaskova E; Sierra RG; Gati C; Goldstone AB; von Bornstaedt D; Shukla P; Wu JC; Wakatsuki S; Woo YJ; Yang PC
    J Am Heart Assoc; 2020 Mar; 9(6):e014345. PubMed ID: 32131688
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade.
    Altomare C; Pianezzi E; Cervio E; Bolis S; Biemmi V; Benzoni P; Camici GG; Moccetti T; Barile L; Vassalli G
    Europace; 2016 Dec; 18(suppl 4):iv67-iv76. PubMed ID: 28011833
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Donor-specific phenotypic variation in hiPSC cardiomyocyte-derived exosomes impacts endothelial cell function.
    Turner A; Aggarwal P; Matter A; Olson B; Gu CC; Hunt SC; Lewis CE; Arnett DK; Lorier R; Broeckel U
    Am J Physiol Heart Circ Physiol; 2021 Mar; 320(3):H954-H968. PubMed ID: 33416449
    [TBL] [Abstract][Full Text] [Related]  

  • 134. Functional and Transcriptional Characterization of Histone Deacetylase Inhibitor-Mediated Cardiac Adverse Effects in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Kopljar I; Gallacher DJ; De Bondt A; Cougnaud L; Vlaminckx E; Van den Wyngaert I; Lu HR
    Stem Cells Transl Med; 2016 May; 5(5):602-12. PubMed ID: 27034410
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Uniaxial cyclic stretch stimulates TRPV4 to induce realignment of human embryonic stem cell-derived cardiomyocytes.
    Qi Y; Li Z; Kong CW; Tang NL; Huang Y; Li RA; Yao X
    J Mol Cell Cardiol; 2015 Oct; 87():65-73. PubMed ID: 26259779
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Human macrophages directly modulate iPSC-derived cardiomyocytes at healthy state and congenital arrhythmia model in vitro.
    Koc A; Akdeniz C; Cagavi E
    Pflugers Arch; 2022 Dec; 474(12):1295-1310. PubMed ID: 36112216
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Evaluation of Batch Variations in Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes from 2 Major Suppliers.
    Huo J; Kamalakar A; Yang X; Word B; Stockbridge N; Lyn-Cook B; Pang L
    Toxicol Sci; 2017 Mar; 156(1):25-38. PubMed ID: 28031415
    [TBL] [Abstract][Full Text] [Related]  

  • 138. PGC-1α activator ZLN005 promotes maturation of cardiomyocytes derived from human embryonic stem cells.
    Liu Y; Bai H; Guo F; Thai PN; Luo X; Zhang P; Yang C; Feng X; Zhu D; Guo J; Liang P; Xu Z; Yang H; Lu X
    Aging (Albany NY); 2020 Apr; 12(8):7411-7430. PubMed ID: 32343674
    [TBL] [Abstract][Full Text] [Related]  

  • 139. Cardiomyocytes derived from human embryonic and induced pluripotent stem cells: comparative ultrastructure.
    Gherghiceanu M; Barad L; Novak A; Reiter I; Itskovitz-Eldor J; Binah O; Popescu LM
    J Cell Mol Med; 2011 Nov; 15(11):2539-51. PubMed ID: 21883888
    [TBL] [Abstract][Full Text] [Related]  

  • 140. An exosomal-carried short periostin isoform induces cardiomyocyte proliferation.
    Balbi C; Milano G; Fertig TE; Lazzarini E; Bolis S; Taniyama Y; Sanada F; Di Silvestre D; Mauri P; Gherghiceanu M; Lüscher TF; Barile L; Vassalli G
    Theranostics; 2021; 11(12):5634-5649. PubMed ID: 33897872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.